000 | 01767 a2200445 4500 | ||
---|---|---|---|
005 | 20250518044932.0 | ||
264 | 0 | _c20200922 | |
008 | 202009s 0 0 eng d | ||
022 | _a1445-2197 | ||
024 | 7 |
_a10.1111/ans.15296 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKerr, David L | |
245 | 0 | 0 |
_aDoes the form of venous thromboembolism prophylaxis following primary total knee arthroplasty alter the rate of early reoperation or revision surgery? _h[electronic resource] |
260 |
_bANZ journal of surgery _c10 2019 |
||
300 |
_a1211-1216 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Systematic Review | ||
650 | 0 | 4 |
_aArthroplasty, Replacement, Knee _xadverse effects |
650 | 0 | 4 |
_aAspirin _xtherapeutic use |
650 | 0 | 4 |
_aAustralia _xepidemiology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 |
_aClinical Decision-Making _xmethods |
650 | 0 | 4 |
_aEnoxaparin _xtherapeutic use |
650 | 0 | 4 |
_aFactor Xa Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPerioperative Period _xstatistics & numerical data |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 |
_aReoperation _xstatistics & numerical data |
650 | 0 | 4 |
_aRivaroxaban _xtherapeutic use |
650 | 0 | 4 | _aSafety |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVenous Thromboembolism _xprevention & control |
700 | 1 | _aButler, Stephen | |
700 | 1 | _aRead, Andrew C | |
700 | 1 | _aHarris, Ian A | |
773 | 0 |
_tANZ journal of surgery _gvol. 89 _gno. 10 _gp. 1211-1216 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ans.15296 _zAvailable from publisher's website |
999 |
_c29831009 _d29831009 |